가천대학교 산학협력단;GACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION
发明人:
KHANG, DONG WOOKR,강동우,LEE, YEON KYUNGKR,이연경,KIM, SANG WOOKR,김상우,HONG, JEONG HEEKR,홍정희,CHOI, YONG HYUNKR,최용현,PARK, JUN YOUNGKR,박준영,KHANG, DONG WOO,LEE, YEON KYUNG,KIM, SANG WOO,HONG, JEONG HEE,CHOI, YONG HYUN,PARK, JUN YOUNG
申请号：
KR1020170050693
公开号：
KR1020180117503A
申请日:
2017.04.19
申请国别(地区):
KR
年份:
2018
代理人:
摘要：
An object of the present invention is to provide a new type of stem cell-nano anticancer drug complex which overcomes limitations of conventional nanocarcinogen drugs and maximizes efficacy of anticancer drugs. The present invention provides the stem cell-nano anticancer drug complex which overcomes limitations of existing stem cell adverse effects and nano-anticancer drugs, has excellent anticancer effect, and is loaded with carbon nanotube (CNT) and gold (Au) nanoparticle-based anticancer drugs on the stem cell surface.COPYRIGHT KIPO 2018본 발명은 기존의 줄기세포 부작용 및 나노 항암제의 표적 한계성을 극복하고 항암제효과도 매우 우수한 줄기세포 표면에 탄소 나노튜브(CNT) 및 금(Au) 나노입자 기반의 항암제가 적재된 줄기세포-나노 항암제 복합체를 제공한다.
